微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 37.67% | 5.19% | 2.58% | 95/142 | 52.32% | 佰仁医疗 | 88.31% | 行业排名> |
| 2026-06-30 | 36.73% | -1.77% | -0.22% | 98/142 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 36.81% | -1.56% | 4.92% | 99/142 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 35.08% | -4.65% | -2.04% | 101/142 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 35.81% | -10.57% | -4.21% | 98/142 | 52.29% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 37.39% | -7.52% | -0.01% | 99/142 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 37.39% | -11.08% | 1.63% | 96/142 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 36.79% | -13.97% | -8.12% | 101/142 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 40.04% | -9.81% | -0.94% | 93/142 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 40.43% | -10.91% | -3.86% | 96/142 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 42.05% | -10.31% | -1.67% | 87/142 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 42.76% | -18.63% | -3.69% | 91/142 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 44.4% | -22.1% | -2.15% | 86/142 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 45.38% | 4.85% | -3.21% | 85/142 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 46.88% | 6.68% | -10.8% | 82/142 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 52.56% | -3.64% | -7.8% | 74/142 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 57% | -1.84% | 31.71% | 62/142 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 43.28% | -25.94% | -1.52% | 88/142 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 43.95% | -28.06% | -19.43% | 80/142 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 54.54% | -6.43% | -6.08% | 81/142 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 58.07% | 2.83% | -0.62% | 64/142 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 58.43% | 7.78% | -4.35% | 67/142 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 61.09% | 26.14% | 4.8% | 54/142 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 58.29% | 32.56% | 3.22% | 75/142 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 56.47% | 25.23% | 4.17% | 58/142 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 54.21% | 14.84% | 11.94% | 73/142 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 48.43% | -0.73% | 10.13% | 51/142 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 43.97% | 7.62% | -2.49% | 87/142 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 45.09% | 7.79% | -4.48% | 41/142 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 47.21% | 18.79% | -3.23% | 46/142 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 48.78% | 29.99% | 19.39% | 28/142 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 40.86% | -1.09% | -2.34% | 79/142 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 41.84% | 4.36% | 5.27% | 34/142 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 39.74% | -0.7% | 5.89% | 42/142 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 37.53% | 11.96% | -9.15% | 36/142 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 41.31% | -0.95% | 3.04% | 75/142 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 40.09% | -6.1% | 0.17% | 32/142 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 40.02% | -4.13% | 19.39% | 41/142 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 33.52% | -9.97% | -19.63% | 38/142 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 41.71% | -1.06% | -2.31% | 58/142 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 42.69% | -0.64% | 2.27% | 26/142 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 41.74% | 1.75% | 12.12% | 33/142 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 37.23% | -1.34% | -11.67% | 28/142 | 50.24% | 健帆生物 | 83.86% | 行业排名> |